Screener
Bioventus BVS Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Bioventus in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Bioventus’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 7:43 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001665988-26-000042
| Line item | June 27, 2026 | December 31, 2025 |
|---|---|---|
| Operating lease assets | 4,225 | 5,122 |
| Deferred tax assets | 29,052 | 5,522 |
| Investment and other assets | 3,507 | 2,293 |
| Total assets | $673,346 | $683,559 |
| Liabilities and Stockholders' Equity | ||
| Current liabilities: | ||
| Accounts payable | $20,196 | $10,928 |
| Accrued liabilities | 109,361 | 130,242 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Bioventus's total assets?
- Bioventus (BVS) reported total assets of $673.35M in Q2 2026.
- How has Bioventus's total assets changed year-over-year?
- Bioventus's total assets decreased by 4.7% year-over-year, from $706.79M to $673.35M.
- What is the long-term trend for Bioventus's total assets?
- Over 5 years (2020 to 2025), Bioventus's total assets has grown at a 6.7% compound annual growth rate (CAGR), from $494.47M to $683.56M.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about Bioventus's total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude